European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.

@article{Spurlock1998EuropeanMA,
  title={European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.},
  author={Gillian Spurlock and Julie Williams and Peter McGuffin and Harald Nikolaus Aschauer and Elisabeth Lenzinger and Karoline Fuchs and Werner Sieghart and Kurt Meszaros and Nahid Fathi and Claudine Laurent and Jacques Mallet and Fabio Macciardi and Steve Pedrini and Michael Gill and Ziarih Hawi and Sian Gibson and Elena E. Jazin and H T Yang and Rolf Adolfsson and Carlos N. Pato and Antonio M. B. Dourado and Michael J Owen},
  journal={American journal of medical genetics},
  year={1998},
  volume={81 1},
  pages={24-8}
}
As part of the European Multicentre Association Study of Schizophrenia (EMASS), we studied polymorphisms in the dopamine DRD2 and DRD3 receptor genes. The EMASS collaboration was established to create a large, statistically powerful sample of schizophrenic patients and controls from different European centres. Previous studies have suggested associations between schizophrenia and the Ser311Cys polymorphism in exon 7 of the dopamine DRD2 receptor gene [Arinami et al., (1994): Lancet 343:703-704… CONTINUE READING